The randomized trial found that reducing sitting time over a 6-month period was association with reduced systolic blood pressure (BP) among a group of older patients with obesity and high rates of hypertension.
Cutting the amount of time spent sitting can help reduce blood pressure for older patients at higher risk for cardiovascular disease, according to study findings published in JAMA Network Open. The randomized trial found that reducing sitting time over a 6-month period was associated with lower systolic blood pressure (SBP) among a group of older patients with obesity and high rates of hypertension.
“This may be because we recruited participants at high risk of hypertension and aimed to reduce sitting time as well as decrease prolonged sitting. Perhaps given a population with higher cardiovascular risk, small changes in sitting patterns were sufficient for improving BP,” the researchers noted. “The promising finding of no significant effect modifiers indicated that people with lower physical function or physical activity or with chronic conditions, such as type 2 diabetes, can reduce their sitting time and reap BP benefits. Decreased sitting could serve as a gateway to more physical activity as people gain strength and confidence.”
The study included 283 patients who were part of a Washington state health care system; half were randomly assigned to a sitting reduction intervention program and the other half were assigned to receive general healthy living tips, thus serving as controls. Patients undergoing the sitting reduction intervention received 10 health coaching sessions, sitting reduction goals, a standing desk, and fitness tracker. Half of patients had hypertension, and the mean body mass index (BMI) was 34.9.
After 6 months, the mean change in sitting time—the study’s primary outcome—decreased significantly more among those receiving the intervention, dropping by approximately a half hour (31.85 minutes) daily. This drop correlated with a drop in SBP of 3.48 mm Hg, which favored the intervention group (95% CI, −6.68 to −0.28; P = .03). The difference in SBP, noted the researchers, was comparable to that observed with physical activity (4 mm Hg), the Dietary Approach to Stop Hypertension diet (5.2 mm Hg), and weight loss (3 mm Hg).
“Our finding that sitting was reduced by approximately 31 minutes per day is slightly lower than others have found and did not meet the study goal of a reduction of 2 hours per day. A Cochrane review of interventions to reduce sitting in older adults, including 7 randomized clinical trials, found an overall reduction of approximately 45 minutes per day, favoring intervention groups. In addition, most of our participants were affected by COVID-19 pandemic restrictions,” noted the researchers, who recruited patients between 2019 and 2022. “Furthermore, the amount of sedentary behavior reduction needed to confer health benefits is not known.”
Patients enrolled in the study during COVID-19 had a greater mean reduction in sitting time (−40.25 min; 95% CI, −65.39 to −15.11; P = .04), although reductions in SBP were similar between those enrolled before (−3.75 mm Hg; 95% CI, −7.27 to −0.23; P = .27) and those enrolled during (−3.41 mm Hg; 95% CI, −9.47 to 2.66; P = .04) the pandemic.
Among secondary and exploratory outcomes, the researchers observed that the intervention was associated with statistically significant increases in time standing and decreases in prolonged periods of sitting. There were no statistically significant differences by weight, BMI, or waist circumference.
Adverse events were reported by 87 patients receiving the intervention and 57 controls. More patients in the intervention group than in the control group had musculoskeletal events (35 vs 19) and skin disorders (9 vs 1). There were 6 serious adverse events in both groups, none of which were study related.
Reference
Rosenberg D, Zhu W, Greenwood-Hickman M, et al. Sitting time reduction and blood pressure in older adults: a randomized clinical trial. JAMA Netw Open. 2024;7(3):e243234. doi:10.1001/jamanetworkopen.2024.3234
With Hidradenitis Suppurativa, Maternal and Offspring Outcomes May Suffer
October 31st 2024Novel evidence has emerged from a 16-year study that hidradenitis suppurativa can elevate risks of not only pregnancy and postpartum complications, but of morbidity—particularly metabolic- and immunology-related morbidity—for mother and child in the long term.
Read More
Building Trust, Breaking Barriers: Health Care Leaders Tackle Primary Care Challenges
August 8th 2024On this episode of Managed Care Cast, we're talking with the chief medical officers of CVS Health and Aetna, as well as CVS Health's chief health equity officer, about primary and preventive care engagement, the impact of telehealth, and the role of trust in patient-provider relationships.
Listen
Low Pulmonary Rehabilitation, Palliative Care Referrals for Patients With IPF Persist
October 30th 2024Despite proven benefits, referrals to pulmonary rehabilitation and palliative care for patients with idiopathic pulmonary fibrosis (IPF) in England remain significantly lower than for other respiratory conditions.
Read More
New AI Tool Identifies Undiagnosed PNH in Health Records
October 30th 2024The machine learning model shows promise in detecting paroxysmal nocturnal hemoglobinuria (PNH) by assessing electronic health records (EHR) data, potentially transforming the diagnostic landscape for rare diseases.
Read More